[HTML][HTML] Individualized prediction models in ADHD: a systematic review and meta-regression

G Salazar de Pablo, R Iniesta, A Bellato, A Caye… - Molecular …, 2024 - nature.com
There have been increasing efforts to develop prediction models supporting personalised
detection, prediction, or treatment of ADHD. We overviewed the current status of prediction …

Practitioner Review: Clinical utility of the QbTest for the assessment and diagnosis of attention‐deficit/hyperactivity disorder–a systematic review and meta‐analysis

A Bellato, CL Hall, MJ Groom… - Journal of Child …, 2024 - Wiley Online Library
Background Several computerised cognitive tests (eg continuous performance test) have
been developed to support the clinical assessment of attention‐deficit/hyperactivity disorder …

Debate: Neurodiversity, autism and healthcare

J Green - Child and Adolescent Mental Health, 2023 - Wiley Online Library
We are at a time of unparalleled flux in our understanding of what autism is and now to
respond to it, including our understanding of the role of clinical services. For any clinician …

[HTML][HTML] DNA Methylation Biomarkers for Young Children with Idiopathic Autism Spectrum Disorder: A Systematic Review

A Stoccoro, E Conti, E Scaffei, S Calderoni… - International journal of …, 2023 - mdpi.com
Autism spectrum disorder (ASD) is a complex neurodevelopmental condition, the underlying
pathological mechanisms of which are not yet completely understood. Although several …

[HTML][HTML] Validation of plasma protein glycation and oxidation biomarkers for the diagnosis of autism

ANJM Al-Saei, W Nour-Eldine, K Rajpoot… - Molecular …, 2024 - nature.com
Abstract Autism Spectrum Disorder (ASD) is a common neurodevelopmental disorder in
children. It is currently diagnosed by behaviour-based assessments made by observation …

[HTML][HTML] Neuron-specific enolase (NSE) as a biomarker for autistic spectrum disease (ASD)

F Stancioiu, R Bogdan, R Dumitrescu - Life, 2023 - mdpi.com
Autistic spectrum disease (ASD) is an increasingly common diagnosis nowadays with a
prevalence of 1–2% in most countries. Its complex causality—a combination of genetic …

[HTML][HTML] The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents …

S Cortese, K McGinn, M Højlund, A Apter… - Neuroscience & …, 2023 - Elsevier
We aimed to identify promising novel medications for child and adolescent mental health
problems. We systematically searched https://clinicaltrials. gov/and https://www …

Umbrella Review: Early-Onset Psychosis: Atlas of the Meta-Analytical Evidence

GS de Pablo, V Rodriguez, F Besana… - Journal of the American …, 2024 - Elsevier
Objective Early-onset psychosis (EOP) refers to the development of psychosis before the
age of 18 years. We aimed to summarize for the first time the meta-analytical evidence in the …

Psychopharmacology in children and adolescents: unmet needs and opportunities

S Cortese, D Purper-Ouakil, A Apter, C Arango… - The Lancet …, 2024 - thelancet.com
Psychopharmacological treatment is an important component of the multimodal intervention
approach to treating mental health conditions in children and adolescents. Currently, there …

Human cortex development is shaped by molecular and cellular brain systems

LD Lotter, A Saberi, JY Hansen, B Misic, GJ Barker… - 2024 - pure.mpg.de
Human brain morphology undergoes complex developmental changes with diverse regional
trajectories. Various biological factors influence cortical thickness development, but human …